Morning Trend | Lonza main force incremental return, is the phase rebound window opening?

Lonza (LZAGY.US) has recently shown significant signs of capital inflow, with the daily K-line regaining an upward trend and a warming sentiment for a phase rebound. The capital rotation in the pharmaceutical CDMO sector is accelerating, and Lonza's position in the industry chain remains solid, with strong market expectations for recovery momentum. On the trading front, the main buying pressure is gradually increasing, and the price has stabilized in the support range for several consecutive days. As global biopharmaceutical investment and financing activities become more active, the prosperity of the company's various business lines is expected to continue, with a clear increase in capital's willingness to replenish leading stocks. If the trading volume follows up in the early session, the short to medium-term rebound window is likely to extend. Pay attention to the breakthrough situation in the core pressure zone of $61-62, which could attract continuous inflow of external capital. However, it is important to note that capital divergence may widen at any time; if there is rapid selling by the main force during the session, the pressure to pull back will also be significant. Short-term trading should focus more on market fluctuations and intraday capital flow to avoid chasing highs and cutting losses. It is recommended to set dynamic stop-losses and respond to sudden market changes with caution